The US Army seeks feedback on a potential research agreement (rOTA) for clinical trials of therapies for neurofibromatosis (NF1, NF2, schwannomatosis), requiring cost-sharing and industry partnership.
This grant funds projects to develop, improve, or make accessible research models, tools, and resources for studying human health and diseases, benefiting multiple NIH Institutes or Centers.
NIH supports development, testing, and clinical feasibility studies of therapeutic and diagnostic devices for nervous or neuromuscular disorders through milestone-driven cooperative agreements.
Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
This grant funds innovative natural history studies to advance medical product development and address unmet needs in rare diseases by generating high-quality, interpretable data.